News

Dr. Jeffrey Fischer Co-Authors FDA LASIK Study on NIDEK EC-5000

Dr. Jeffrey Fischer recently co-authored a FDA study, measuring the safety and effectiveness of the NIDEK EC-5000 excimer laser system's Customized Aspheric Treatment Zone(CATZ) for the treatment of myopia with and without astigmatism.

This CATZ LASIK treatment profile allows for a smoother transition between treated and untreated cornea.Another unique feature of this treatment is the only excimer laser capable of performing laser vision correction using a topography guided treatment. This individually customized LASIK treatment allows for better post operative vision, and also the reduced possibility of glare.

In the study conducted by the United States Food and Drug Administration, Dr. Fischer and six other doctors across the country assessed the efficacy, predictability and safety of LASIK on patients. Results after surgery concluded that 89% of patients treated had 20/20 vision or better. In addition patients reported significantly fewer night driving, glare and halo complaints post operatively than pre operatively.

The outcome of the study reports that the corrective surgery surpassed all FDA criteria.

Have you heard of the NEW Crystalens® accommodating IOL technology? Dr. Fischer is now a certified Crystalens® surgeon in Minnesota.

If you have heard of the hassles of developing cataracts and are concerned about seeing an ophthalmologist to correct this vision condition please contact Family Eye Center immediately. Dr. Jeffrey Fischer at Family Eye Center now has the technology, experience and capability to insert a revolutionary lens implant technology known as Crystalens®. This advancement is lens technology will benefit senior aged patients who may be developing cataracts. When a cataract does occurs in the eye, one of the biggest issues is that the lens hardens and does not flex or move to accommodate your vision. This new lens technology is a man made IOL that can actually react more like your natural crystalline lens. The end result is better vision at not only one distance, but multiple distances.

If your eye doctor has told you that you are at the beginning stages of developing cataracts or has suggested that refractive lens exchange would be a good vision correction option, you might want to research the new emerging lens implant technology. The advantages a lens like this could bring to your vision are simply incredible! Some patients have described the experience as returning their vision to how they could see in their twenties.

Who can benefit from the Crystalens®?

This new intraocular lens technology of modern eye surgery has created advancements that can dramatically improve a patient's ability to see with lens implants after cataract surgery. Some of these new intraocular lens implants might even be a better vision correction option than LASIK eye surgery depending on your prescription and age. In the past with LASIK eye surgery our doctors could correct myopia, hyperopia and astigmatism. Now with the advent of premium multifocal IOL lens implants, the giant burden of presbyopia can now be corrected. Presbyopia affects a vast part of our aging population and often requires bifocal glasses. People in their mid forties that have trouble with reading and typically experiencing the first effects of presbyopia. Presbyopia is an accommodation problem with the lens of the eye. As the lens hardens and becomes inflexible the ability to focus becomes harder. Accommodating or multifocal lens implants can now be used to replace the clouded lens, allowing a patient to focus properly.

Dr. Tom Lenz Joins the Family Eye Center Dr. Lenz grew up in Renville and graduated from Concordia College. He then earned his doctor of optometry from the Illinois College of Optometry, where he was awarded the Dr. Myrel A. Neumann Scholarship for clinical excellence.In addition to providing primary eye care, Dr. Lenz is our low vision specialist. Dr. Lenz practices at Family Eye Center's Willmar and Olivia offices.

NEW Selective Laser Procedure at Family Eye Center Selective Laser Trabeculoplasty (SLT) is an exciting new glaucoma treatment that lowers eye pressure in a safe, effective, in office procedure. This procedure only takes a few minutes and is covered by most insurance companies. In some cases this revolutionary procedure eliminates or reduces the need for eye drops. In the past glaucoma surgeries have been either ineffective or only used in severe cases. This low risk treatment option has changed the way glaucoma is being treated and in some cases is used as an initial treatment option before using any eye drops.

State of the art technology at Family Eye Center In pursuit of the latest technology available, Family Eye Center and Fischer Laser Eye Center use two of the most advanced diagnostic tools available. The Oculus Pentacam and the Nidek OPD Scan provide more diagnostic information than any other comparable instrumentation.

Think you’re a candidate for LASIK?

At Fischer Laser Eye Center we use the latest technology to help determine whether or not you are a candidate for LASIK. Using state of the art diagnostic equipment such as the Oculus Pentacam and Nidek OPD SCAN, we can analyze the cornea from front to back to rule out any corneal problems or "red flags." Our comprehensive LASIK consultation takes 1-1.5 hours. During this exam we discuss which LASIK treatment is most appropriate for your individual situation. We do not believe in a one size fits all mentality. We consider prescription, eye health, age, occupation, hobbies and overall lifestyle to customize your LASIK experience. The decision to have LASIK is a major decision in your life. There is a wealth of information available in advertisements and the media about LASIK. Our goal is to educate you about LASIK in general, discuss realistic expectations for your individual situation, and provide you with enough information to allow you to determine whether or not LASIK is right for you.

STAAR Surgical's VISIAN ICL™ Receives FDA Approval MONROVIA, CA

-- December 23, 2005 -- STAAR Surgical Company reported that the U.S. Food and Drug Administration (FDA) has approved the Company's Myopic VISIAN ICL(TM) for use in the correction of myopia in adults.

Made of STAAR's proprietary, highly biocompatible Collamer(R) material, the ICL (Implantable Collamer Lens) is the only minimally invasive foldable lens of its kind approved for the U.S. commercial market.